Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal
German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio ... Read More
Bayer to acquire KaNDy Therapeutics to add menopause drug candidate
Bayer has agreed to acquire KaNDy Therapeutics, a UK clinical-stage biotech company, in a deal worth up to $900 million, in a move to grow ... Read More
Bayer gets Lampit FDA approval for Chagas disease in pediatric patients
Lampit FDA approval : Bayer has bagged approval for its antiprotozoal medication Lampit (nifurtimox) from the US Food and Drug Administration (FDA) for the treatment ... Read More
Bayer completes sale of animal health business to Elanco
Bayer has wrapped up its previously announced $7.6 billion sale of its animal health business division to US-based Elanco Animal Health. The transaction, which was ... Read More
Macquarie to acquire Currenta from Bayer and Lanxess for €3.5bn
German pharma company Bayer and specialty chemicals company Lanxess have signed corresponding agreements with Macquarie Infrastructure and Real Assets (MIRA) to sell their stakes in ... Read More
Eli Lilly completes $8bn acquisition of Loxo Oncology to expand oncology portfolio
Eli Lilly and Company, the US-based pharmaceutical giant, has finalised its $8 billion acquisition of Connecticut-based biopharmaceutical firm Loxo Oncology, a move expected to significantly ... Read More
Bayer and Janssen’s Xarelto shows promising results in reducing blood clot recurrence
Bayer AG and Janssen Pharmaceuticals, two giants in the pharmaceutical industry, have announced significant findings from their EINSTEIN CHOICE clinical trial, showcasing the effectiveness of ... Read More